en are more prone to develop hypertension and renal dysfunction compared with premenopausal women of the same age.
M
en are more prone to develop hypertension and renal dysfunction compared with premenopausal women of the same age. [1] [2] [3] Sexual dimorphism in hypertension and renal dysfunction was demonstrated in various animal models of hypertension, including angiotensin II and deoxycorticosterone acetate-salt-induced hypertension, Dahl salt-sensitive, and spontaneously hypertensive rats (SHR). In particular, males are more likely to develop hypertension and renal dysfunction compared with females in these models. [4] [5] [6] [7] [8] [9] [10] Testosterone stimulates the expression of renal angiotensinogen or urinary excretion of angiotensinogen in SHRs and in angiotensin II-high salt (HS) diet-induced hypertension. [11] [12] [13] Moreover, castration decreases expression of renal renin and angiotensinogen and hepatic angiotensinogen in male SHRs. 11, 12 Angiotensin II infusion also increases angiotensin II type 1a receptor (AT1a) expression in male SHRs 14 or alters the angiotensin II type 2 receptor (AT2) to AT1a receptor balance in kidneys of male SHRs. 15 Furthermore, angiotensin II decreases the expression of Mas receptor and angiotensin-converting enzyme 2 (ACE 2) mRNA in male SHR and Sprague-Dawley (SD) rats. 14, 16 Dihydrotestosterone-induced hypertension in rats expressing endothelial cytochrome P-450 4A2 (CYP4A2) depends on the prohypertensive eicosanoid 20-hydroxyeicosatetraenoic acid (20-HETE), 17 and is associated with increased vascular expression of ACE. 18 Hypertension is also associated with inflammation. [19] [20] [21] In males, angiotensin II infusion increases vascular and renal infiltration of CD4 + and CD8 + T-lymphocytes. 21, 22 Adaptive transfer of T-cells from male mice into male Rag1 -/-mice increases blood pressure (BP), but transfer of T-cells from female mice does not elicit a similar response. 23 These observations indicate that in males, testosterone downregulates the antihypertensive components and upregulates the hypertensive components of the reninangiotensin and immune systems and thereby contributes to increased BP and renal dysfunction.
Cytochrome P-450 (CYP)1B1, which is highly expressed in the cardiovascular and renal systems and is capable of metabolizing fatty acids, retinoids, and sex steroids, contributes to the development of hypertension and renal dysfunction in male mice. [24] [25] [26] In female mice, where angiotensin II-induced increases in BP and renal dysfunction are minimized as compared with male mice, inhibition of CYP 1B1 activity with 2,3′,4,5′-tetramethoxystilbene or Cyp1b1 gene disruption (Cyp1b1 −/− ) abrogated this protection against angiotensin II to increased BP and causes renal dysfunction. 26, 27 These protective effects of CYP1B1 against angiotensin II in female mice are diminished by treatment with 2-methoxyestradiol, which is formed from a estradiol metabolite of Cyp1b1, 2-OH estradiol, and by catechol-O-methyltransferase. 28, 29 Testosterone is metabolized into dihydrotestosterone by 5α-reductase, 6β-hydroxytesto sterone, and 16α-hydroxytestosterone by CYP1B1. 30, 31 Angiotensin II increases selectively the production of 6β-hydroxytestosterone but not 16α-dihydrotestosterone, which is abolished by Cyp1b1 gene disruption. Recently, we have shown that 6β-hydroxytestosterone contributes to angiotensin II-induced increase in BP and associated cardiac pathophysiological changes in male mice. 32 These observations led us to hypothesize that 6β-hydroxytestosterone also contributes to angiotensin II-induced renal dysfunction and end-organ damage in male mice. To test this hypothesis, we examined the effects of angiotensin II and 6β-hydroxytestosterone on angiotensin II-induced renal dysfunction and end-organ damage in intact and castrated Cyp1b1 +/+ and Cyp1b1 −/− male mice. The results show that angiotensin II-induced renal dysfunction and endorgan damage are associated with increased renal oxidative stress, production of angiotensinogen, and inflammation; these effects are minimized in Cyp1b1 −/− and castrated Cyp1b1 +/+ mice and restored by 6β-hydroxytestosterone.
Methods
All experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and the protocols approved by our Institutional Animal Care and Use Committee. Experiments were performed in 8-weekold, 20 to 25 g body weight, both intact and castrated Cyp1b1 +/+ and Cyp1b1 −/− mice. These mice were infused with angiotensin II (700 ng/kg per minute) or saline (vehicle) for 14 days with subcutaneously implanted micro osmotic pumps. In another series of experiments, 6β-hydroxytestosterone (15 µg/g IP every third day) or its vehicle was given concurrently with angiotensin II infusion in both intact and castrated mice. Water intake, urine output, renal function, renal oxidative stress, end-organ damage, and T-cell infiltration were assessed in the same groups of mice that were used in the previous study 32 to reduce the number of animals used and to comply with the 3R guidelines set by the Institutional Animal Care and Use Committee. Detailed experimental Methods are available in the online-only Data Supplement.
Statistical Analysis
Data were analyzed by 2-way ANOVA followed by Tukey multiple comparison post hoc test or Student t test. The values of 3 to 8 different experiments are expressed as the mean±SEM. P<0.05 was considered statistically significant.
Results

Cyp1b1 Gene Disruption Minimized Angiotensin IIInduced Increase in Water Intake and Renal Dysfunction
We have previously shown that 6β-hydroxytestosterone contributes to angiotensin II-induced increase in BP and associated cardiac pathophysiological changes in male mice. 32 In the present study, we examined angiotensin II-induced changes in renal function and associated pathogenesis in these animals. Infusion of angiotensin II for 2 weeks increased systolic BP (SBP), measured by tail cuff every third day, in Cyp1b1 +/+ and Cyp1b1 −/− mice, but the increase was significantly less in Cyp1b1 −/− than in Cyp1b1 +/+ mice (Table S1 in the online-only Data Supplement). Angiotensin II also increased water intake and urine output in Cyp1b1 +/+ mice; this increase was minimized in Cyp1b1 −/− mice (Table S1 ). Angiotensin II infusion did not alter plasma levels of creatinine in Cyp1b1 +/+ or in Cyp1b1 −/− mice (Table  S1 ). Angiotensin II infusion decreased urine osmolality, increased urinary excretion of Na + , and caused proteinuria in Cyp1b1 +/+ but not in Cyp1b1 −/− mice (Table S1 ). The difference in the renal functional parameters observed between these 2 groups was consistent, reproducible, and similar to that reported previously. As previously shown, the effect of angiotensin II to increase BP was minimized in intact Cyp1b1 −/− and castrated Cyp1b1 +/+ mice. 6β-Hydroxytestosterone, which did not alter basal BP, restored the effect of angiotensin II to increase SBP in intact Cyp1b1 −/− and castrated Cyp1b1 +/+ mice (Table S1 ). Cyp1b1 gene disruption mitigated the effects of angiotensin II to cause renal dysfunction; treatment with 6β-hydroxytestosterone in Cyp1b1 −/− mice restored the ability of angiotensin II to cause an increase in water intake and renal dysfunction to the levels that were observed in Cyp1b1 +/+ mice (Table S1 ). Castration minimized the effect of angiotensin II to increase SBP, water intake, or cause renal dysfunction in Cyp1b1 +/+ mice (Table S1 ). In castrated Cyp1b1
+/+ and Cyp1b1 −/− mice, administration of 6β-hydroxytestosterone restored the effects of angiotensin II to increase SBP, water intake, and cause renal dysfunction. 6β-Hydroxytestosterone did not alter water intake or renal function in animals infused with vehicle of angiotensin II (Table S1 ).
staining and collagen deposition in the kidneys ( Figure 1A and 1B, top). Treatment with 6β-hydroxytestosterone restored the effects of angiotensin II in Cyp1b1 −/− mice but did not alter these effects of angiotensin II in Cyp1b1 +/+ mice ( Figure 1C and 1D, bottom). Figure S2A and S2B). 6β-Hydroxytestosterone alone did not cause renal fibrosis in castrated mice of these genotypes (Figure S1A and S1B; Figure S2A and S2B). 
Castration Prevents
Cyp1b1 Gene Disruption or Castration Minimized Urinary Excretion of Angiotensinogen, Which Was Restored by 6β-Hydroxytestosterone Treatment
Angiotensin II infusion increases intrarenal accumulation and urinary excretion of angiotensinogen 33 and renal production of angiotensin II, which have been implicated in the development of hypertension. 33 Angiotensin II increased urinary excretion of angiotensinogen in Cyp1b1 +/+ mice ( Figure 3A ). Cyp1b1 gene disruption or castration minimized urinary angiotensinogen increase by angiotensin II without altering basal levels ( Figure 3 ). Figure S8 ).
Castration Decreased Renal Expression of ACE and
Cyp1b1 Gene Disruption or Castration Decreased Interleukin-6 and Interferon-γ mRNA Expression, Which Was Restored by 6β-Hydroxytestosterone
As shown above, Cyp1b1 gene disruption or castration decreased renal accumulation of CD4 + T-cells, which was restored by 6β-hydroxytestosterone. We examined the effects of Cyp1b1 gene disruption and castration on cytokine interleukin-6 and interferon-γ mRNA expression and their restoration by 6β-hydroxytestosterone. Cyp1b1 disruption or castration decreased interleukin-6 and interferon-γ expressions ( Figure  S9A and S9B), and treatment with 6β-hydroxytestosterone restored expression of mRNA encoding interleukin-6 and interferon-γ in castrated Cyp1b1 +/+ and Cyp1b1 −/− mice ( Figure S9A and S9B).
Restoration by 6β-Hydroxytestosterone of the Effect of Angiotensin II on Renal Fibrosis Is Dependent on SBP in Cyp1b1 −/− Mice
To determine whether the effect of 6β-hydroxytestosterone to restore the effect of angiotensin II on renal fibrosis in Cyp1b1 −/− mice is dependent on SBP, we examined the effect of a direct vasodilator hydralazine (250 mg/L in drinking water) on SBP and renal fibrosis. Hydralazine reduced SBP ( Figure S10A ) and renal fibrosis, as indicated by decreased interstitial α-SMA staining and collagen deposition in the kidneys of Cyp1b1 −/− mice infused with angiotensin II and concurrently treated with 6β-hydroxytestosterone ( Figure S10B ).
Discussion
The main findings of this study are that 6β-hydroxytestosterone, a CYP1B1-generated metabolite of testosterone, contributes to the following: angiotensin II-induced (1) increase in water intake, (2) renal dysfunction, (3) end-organ damage, (4) increased BP, (5) increased oxidative stress, (6) intrarenal production of angiotensinogen, and (7) activation T-cells in male mice. Previously, we reported that Cyp1b1 gene disruption or inhibition of CYP1B1 activity minimized angiotensin II-induced renal dysfunction and end-organ damage in male mice. 25 Moreover, we showed that angiotensin II stimulates the production of 6β-hydroxytestosterone, a testosterone-derived metabolite of CYP1B1, in Cyp1b1
mice, and contributes to angiotensin II-induced hypertension and associated cardiac pathophysiology by acting as a permissive factor. 32 The current study assessed the renal function and associated pathophysiological changes in these mice 32 and has revealed that angiotensin II infusion for 14 days increased water intake and urine output in Cyp1b1 +/+ mice, and these effects of angiotensin II were minimized in Cyp1b1 −/− mice, thus confirming our previous results. 25 Administration of 6β-hydroxytestosterone to Cyp1b1 −/− mice that do not generate this testosterone metabolite 32 restored the effects of angiotensin II to increase thirst and urine output, suggesting that 6β-hydroxytestosterone contributes to this effect of angiotensin II in male mice, most likely by acting in the brain.
Angiotensin II increased urinary Na + excretion in Cyp1b1 +/+ mice, and Cyp1b1 gene disruption minimized Na + excretion in male mice. 25 In the present study, we found that administering 6β-hydroxytestosterone to Cyp1b1 −/− mice infused with angiotensin II markedly increased Na + excretion. The increase in urinary Na + excretion by angiotensin II in the Cyp1b1 +/+ mice, and its restoration by 6β-hydroxytestosterone in Cyp1b1 −/− mice, is most likely the consequence of increase in BP. Further studies are needed to determine the fractional Na + excretion and its time-course and total body Na + to address the roles of CYP1B1 and 6β-hydroxytestosterone in angiotensin II actions to alter Na + balance in male mice. 6β-Hydroxytestosterone also contributed to the effect of angiotensin II to decrease osmolality, cause proteinuria, and renal fibrosis, as indicated by interstitial α-SMA and collagen accumulation, because these effects of angiotensin II that were abrogated in Cyp1b1 gene disrupted mice were significantly restored by 6β-hydroxytestosterone. Further support for the role of 6β-hydroxytestosterone in angiotensin II-induced renal dysfunction and end-organ damage was obtained in castrated mice. Castration attenuated angiotensin II-induced renal dysfunction and fibrosis in Cyp1b1 +/+ mice, but, as expected, castration did not have any effect in Cyp1b1 −/− mice infused with angiotensin II. However, concurrent administration of 6β-hydroxytestosterone restored the effects of angiotensin II to cause renal dysfunction and fibrosis in both castrated Cyp1b1 +/+ and Cyp1b1 −/− mice. The mechanism by which 6β-hydroxytestosterone mediates the effect of angiotensin II to cause end-organ damage in intact Cyp1b1 −/− and castrated Cyp1b1 +/+ mice could be because of restoration of the effect of angiotensin II on BP by 6β-hydroxytestosterone. 32 Supporting this view was our observation that hydralazine that abolished the increase in SBP prevented renal fibrosis caused by angiotensin II in Cyp1b1 −/− mice treated with 6β-hydroxytestosterone. However, we cannot exclude any possible action of hydralazine on ≥1 signaling mechanisms involved in the action of angiotensin II because angiotensin II has also been reported to cause fibrosis independent of an increase in BP. [34] [35] [36] [37] Angiotensin II increases production of ROS, which contributes to the development of hypertension and end-organ damage in male SHR rats. [38] [39] [40] Moreover, Cyp1b1 gene disruption and inhibition of its activity decrease vascular and renal oxidative stress in rats and mice. [23] [24] [25] Our finding that administration of 6β-hydroxytestosterone to Cyp1b1 −/− or castrated Cyp1b1 +/+ mice infused with angiotensin II increased renal NADPH oxidase activity and ROS production suggests that 6β-hydroxytestosterone, by restoring the effect of angiotensin II to increase oxidative stress, contributes to the development of renal dysfunction and end-organ damage in male mice.
Treatment with dihydrotestosterone has been shown to increase the renal vascular expression of CYP4A8 and its ortholog CYP4A12 in male mice, thereby stimulating prohypertensive eicosanoid 20-HETE production and increasing the activity of the renin-angiotensin system (RAS) and BP. 18, 41, 42 Dihydrotestosterone-induced hypertension was minimized in angiotensinogen-deficient mice.
43 Cyp1b1 gene disruption in male mice did not alter renal expression of CYP4A10/12/14 (mouse orthologs of rat CYP4A1/ A2/A3). 25 In the present study, expression of CYP4A12A mRNA was decreased in the kidneys of both Cyp1b1 48 Infusion of angiotensin II increased AT1a receptor expression in male SHRs, but not SD rats. 14, 16 Renal mRNA expression of ACE2, AT2, and plasma levels of angiotensin 1 to 7 are increased in female SHRs compared with male SHRs, and this increase in AT2 mRNA and angiotensin 1 to 7 has been proposed to be responsible for the lower BP in female SHRs than in male SHRs. [14] [15] [16] In the present study, angiotensin II infusion did not alter renal AT1a or ACE expression in either Cyp1b1 +/+ or Cyp1b1 −/− mice. However, castration attenuated both AT1a and ACE mRNA expression in both genotypes, and treatment with 6β-hydroxytestosterone increased AT1a and ACE mRNA expression in both mouse genotypes. Castration or 6β-hydroxytestosterone had no effect on expression of ACE2 expression in either group of mice infused with angiotensin II or its vehicle, suggesting that castration downregulated the prohypertensive arm of the RAS, and treatment with 6β-hydroxytestosterone upregulated the prohypertensive arm of the RAS.
An increase in urinary excretion of angiotensinogen is a marker for increased intrarenal RAS activity. 33, 49 Angiotensin II infusion increased renal expression and urinary excretion of angiotensinogen in male rats, suggesting that there is an increased angiotensinogen availability for conversion to angiotensin II in kidneys. 13, 33, [50] [51] [52] [53] In Dahl salt-sensitive male rats, a high-salt diet increased intrarenal angiotensinogen expression, BP, proteinuria, and glomerulosclerosis, which were prevented by castration and restored by administering testosterone, suggesting that angiotensin II-induced intrarenal angiotensinogen production depends on androgens. 54 Our previous study showing that angiotensin II-stimulated production of testosterone metabolite 6β-hydroxytestosterone via CYP1B1 32 together with the demonstration that the angiotensin II-induced increase in urinary excretion of angiotensinogen was inhibited by Cyp1b1 gene disruption or castration in Cyp1b1 +/+ mice, and that treatment with 6β-hydroxytestosterone restored the increase in urinary excretion of angiotensinogen in these mice suggest that 6β-hydroxytestosterone contributes to angiotensin II-induced intrarenal angiotensinogen production. Increased availability of intrarenal angiotensinogen coupled with increased renal ACE expression and AT1a receptor expression may augment the effects of angiotensin II to cause renal dysfunction and end-organ damage. The mechanism by which 6β-hydroxytestosterone mediates increased urinary excretion of angiotensinogen that could be because of enhanced transcription of angiotensinogen by angiotensin II remains to be determined.
Angiotensin II also stimulates the immune system and causes infiltration of macrophages and T-cells in blood vessels, kidneys, and central nervous system resulting in increased BP and end-organ damage. 55 This increase in BP is attenuated in Rag1 −/− deficient male mice and restored by adoptive transfer of male wild-type T-cells. 56 Recent studies also showed that adoptive transfer of male wild-type T-cells to Rag1 
T-cells in Cyp1b1
−/− mice but failed to do so in castrated mice. These results suggest that 6β-hydroxytestosterone is insufficient to restore angiotensin II-induced infiltration of CD4 + T-cells, and testosterone and its metabolite dihydrotestosterone are required for accumulation of these cells in castrated mice. However, further in-depth studies are required to assess the role of 6β-hydroxytestosterone in the action of angiotensin II on other subtypes of T-lymphocytes and dendritic cells and production of cytokines in renal dysfunction and end-organ damage. Moreover, in view of the recent evidence that the dendritic cell isoketal-modified proteins activate T-cells and promote hypertension, the possibility that testosterone and its metabolite 6β-hydroxytestosterone-dependent activation of T-cells by angiotensin II might be mediated via formation of dendritic cell isoketal-modified proteins 59 remains to be explored.
The mechanism by which 6β-hydroxytestosterone contributes to the effects of angiotensin II to increase thirst, renal dysfunction, oxidative stress, inflammation, and end-organ damage is unclear. Because 6β-hydroxytestosterone restored these effects of angiotensin II in both intact Cyp1b1 −/− and castrated Cyp1b1 +/+ mice without producing these effects alone, it seems that it acts as a permissive factor to increase sensitivity to the action of angiotensin II, most likely by interacting with AR, which is located on mesangial cells, glomeruli, proximal tubules, and cortical collecting ducts. 60, 61 Therefore, whether 6β-hydroxytestosterone restores the renal actions of angiotensin II through genomic and nongenomic AR or independent of AR remains to be determined. 62, 63 Because expression of AR mRNA in the kidney was not altered either in Cyp1b1 or castrated mice treated with 6β-hydroxytestosterone or its vehicle, the effect of 6β-hydroxytestosterone-mediated angiotensin II-induced renal pathophysiological changes seems to be independent of AR expression. This observation together with our finding that 6β-hydroxytestosterone did not alter either basal BP or renal function, or angiotensin II-induced increase in BP or renal dysfunction and end-organ damage in Cyp1b1 +/+ mice, suggests that its effects are unlikely to be because of competition with testosterone or dihydrotestosterone at the AR.
In conclusion, this study provides evidence that the testosterone metabolite of Cyp1b1, 6β-hydroxytestosterone stimulated by angiotensin II, contributes to its actions to increase thirst, renal dysfunction, fibrosis, oxidative stress, angiotensinogen production, and inflammation in male mice. In contrast, we have shown that, in female mice, CYP1B1 protects against angiotensin II-induced hypertension and renal dysfunction via metabolism of estradiol to 2-hydroxyestradiol and subsequently its metabolism by catechol-O-methyltransferase to 2-methoxyestradiol 28,29 that acts as a permissive factor to by guest on August 30, 2017 http://hyper.ahajournals.org/ Downloaded from suppress angiotensin II actions. 26 Therefore, it seems that 17β-estradiol and testosterone metabolites of CYP1B1 contribute to sex differences in angiotensin II-induced renal dysfunction and end-organ damage associated with hypertension. Finally, CYP1B1 could serve as a novel target for developing agents that inhibit CYP1B1 for treating renal dysfunction in males, but inhibitors of CYP1B1 could be detrimental in treating renal dysfunction and hypertension in females. Because CYP1B1 is known to cause congenital glaucoma 64 because of a developmental abnormality in the eye, 64 acute or chronic inhibition of CYP1B1 in adults may not cause increased ocular pressure. However, this possibility needs to be assessed in the development of CYP1B1 inhibitors in the treatment of renal dysfunction and hypertension in males.
Perspectives
Sex differences in renal dysfunction in various models of experimental hypertension have been attributed to sex chromosome complement and sex hormones. The present study provides evidence that the CYP1B1 metabolite of testosterone, 6β-hydroxytestosterone, in male mice contributes to angiotensin II-induced increases in thirst, renal dysfunction, and endorgan damage most likely by increased oxidative stress and intrarenal RAS activity and activation of T-cells. The levels of testosterone decrease with age in men, and many individuals including females are prescribed testosterone for sexual dysfunction and to increase muscle mass and boost energy. However, the use of testosterone with regard to cardiovascular effects, benefits versus risk are controversial. Because angiotensin II increases the production of 6β-hydroxytestosterone that contributes to its hypertensive and pathophysiological effects, it would be important to determine the levels of this testosterone metabolite in individuals of different ages with increased activity of RAS. Moreover, in view of polymorphism in human CYP1B1 gene 64 and differences in the catalytic properties of polymorphic CYP1B1 variants for steroid hormones including testosterone, 65 it would be important to determine association of CYP1B1 gene polymorphism to the levels of testosterone and its metabolites, BP, and renal function.
• Provides the evidence that 6β-hydroxytestosterone mediates the effect of angiotensin II to produce renal fibrosis and oxidative stress in male mice.
• Demonstrates that Cyp1b1 gene disruption or castration decreases angiotensin II-induced urinary excretion of angiotensinogen, which is restored by 6β-hydroxytestosterone.
• Demonstrates that 6β-hydroxytestosterone mediates the effect of angiotensin II to increase renal infiltration of CD4+ T-cells.
What Is Relevant?
• This study advances our knowledge of the mechanism by which CY-P1B1-testosterone-derived metabolite 6β-hydroxytestosterone contributes to angiotensin II-induced renal dysfunction, fibrosis, oxidative stress, and inflammation in males.
• Our demonstration that 6β-hydroxytestosterone mediates the action of angiotensin II to stimulate intrarenal angiotensinogen production coupled with increased mRNA expression of AT1a receptor and angiotensinconverting enzyme. This furthers our understanding of the mechanism of testosterone-dependent activation of intrarenal renin-angiotensin system by angiotensin II and has important pathophysiological significance in the development of renal disease and hypertension.
• Finally, our study has translational significance in developing selective CYP1B1 inhibitors for treating testosterone-dependent angiotensin IIinduced renal dysfunction, end-organ damage, and hypertension in men.
Summary
Angiotensin II increased renal dysfunction, fibrosis, oxidative stress, inflammation, and urinary excretion of angiotensinogen in male mice. Cyp1b1 gene disruption or castration in Cyp1b1 +/+ mice minimized these effects of angiotensin II. Administering the testosterone metabolite formed by CYP1B1, 6β-hydroxytestosterone to Cyp1b1 −/− or castrated Cyp1b1 +/+ mice restored the ability of angiotensin II to increase thirst and cause renal dysfunction, fibrosis, oxidative stress, inflammation, and urinary excretion of angiotensinogen in male mice. Because 6β-hydroxytestosterone increased intrarenal angiotensinogen and mRNA expression of AT1a receptor and ACE in Cyp1b1 gene-disrupted or castrated mice infused with angiotensin II, it seems that 6β-hydroxytestosterone promotes increased formation of angiotensin II in the kidneys, thereby contributing to renal dysfunction and associated pathogenesis in male mice. Therefore, developing selective inhibitors of CYP1B1 could be useful for treating reninangiotensin and testosterone-dependent renal disease and hypertension in males. +/+ and Cyp1b1 -/-mice were infused with vehicle (Veh) or Ang II and given intraperitoneal injections of testosterone metabolite, 6β-OHT, every third day for 2 weeks. At the end of Ang II infusion, kidneys were isolated for measurement of mRNA encoding (A) AT1a receptor and (B) ACE, as described in methods. mRNA expression was normalized against β-actin(ACTB), which was used as a housekeeping gene control, and calculated according to ΔΔCt method. -/-mice were infused with vehicle (Veh) or Ang II and given intraperitoneal injections of testosterone metabolite, 6β-OHT, every third day for 2 weeks. At the end of Ang II infusion, the kidneys were isolated for measurement of mRNA expression of (A) ACE2 and (B) AR , as described in Methods. mRNA expression was normalized against ACTB mRNA, which was used as a housekeeping gene, and calculated according to ΔΔCt method. (n=3 for each experimental group; data are expressed as mean±SEM) +/+ and Cyp1b1 -/-mice. Cyp1b1 +/+ and Cyp1b1 -/-mice were infused with vehicle (Veh) or Ang II for 2 weeks. At the end of Ang II infusion, kidneys were isolated for measurement of mRNA encoding (A) CYP1B1 and (B) CYP4A12A, as described in methods. mRNA expression was normalized against ACTB, which was used as a housekeeping gene, and calculated according to ΔΔCt method. *P<0.05 vehicle vs. corresponding value from Ang II-infused animals (n=3 for each experimental group; data are expressed as mean±SEM). +/+ and Cyp1b1 -/-mice which is restored by 6β-OHT. Intact or castrated Cyp1b1 +/+ and Cyp1b1 -/-mice were infused with vehicle (Veh) or Ang II and given intraperitoneal injections of the testosterone metabolite, 6β-OHT, every third day for 2 weeks. At the end of Ang II infusion, kidney was isolated for measurement of mRNA encoding (A) IL6 and (B) IFN-γ, as described in methods. mRNA expression was normalized against β-actin(ACTB), which was used as a housekeeping gene, and calculated according to ΔΔCt method.
